15-48425410-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 5P and 4B. PM1PP2PP3_ModerateBS2
The NM_000138.5(FBN1):āc.7412C>Gā(p.Pro2471Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251366Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135850
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727230
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74328
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
Segregated with disease in some affected relatives, but the variant was absent in other affected relatives (PMID: 25652356); Reported in a female with mitral valve prolapse and premature ventricular contractions who also harbors a pathogenic variant in the DSP gene (PMID: 32277046); Although located in a calcium-binding EGF-like domain of the FBN1gene, it does not affect a cysteine residue within this domain; cysteine substitutions in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with FBN1-related disorders (PMID: 12938084); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28391405, 31019026, 26017485, 28941062, 25644172, PuppoMoreno2023, 25652356, 32277046, 12938084) -
- -
Marfan syndrome;C0265287:Acromicric dysplasia;C1858556:MASS syndrome;C1861456:Stiff skin syndrome;C1869115:Weill-Marchesani syndrome 2, dominant;C3280054:Geleophysic dysplasia 2;C3541518:Ectopia lentis 1, isolated, autosomal dominant;C4310796:Progeroid and marfanoid aspect-lipodystrophy syndrome Pathogenic:1Uncertain:1
- -
- -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 2471 of the FBN1 protein (p.Pro2471Arg). This variant is present in population databases (rs193922233, gnomAD 0.009%). This missense change has been observed in individuals with clinical features of FBN1-related conditions (PMID: 25644172, 25652356, 26017485, 28941062; internal data). ClinVar contains an entry for this variant (Variation ID: 36115). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt FBN1 protein function with a positive predictive value of 95%. This variant disrupts the p.Pro2471 amino acid residue in FBN1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27906200). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Marfan syndrome Uncertain:1
- -
not specified Uncertain:1
Variant summary: FBN1 c.7412C>G (p.Pro2471Arg) results in a non-conservative amino acid change located in an EGF-like repeat domain (IPR000742) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.5e-05 in 1,614,000 control chromosomes (gnomAD v4.1 dataset). This frequency is not higher than the estimated maximum expected for a pathogenic variant in FBN1 causing Marfan Syndrome (0.00011), allowing no conclusion about variant significance. c.7412C>G has been reported in the literature in individuals affected with suspected Marfan Syndrome (MS) and MS-related conditions including abdominal aortic aneurysm, thoracic aortic disease, mitral prolapse and ectopia lentis (e.g. Baudhuin_2015, van de Luijtgaarden_2015, Campens_2015, Vatti_2017, Gago-Diaz_2017, Clark_2019). However, in some of these cases co-occurring variants could potentially explain the phenotype (Vatti_2017, van Wjingaarden_2020), although an additive effect of these variants cannot be excluded. These reports do not provide unequivocal conclusions about association of the variant with Marfan Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25652356, 25644172, 31019026, 28391405, 28941062, 32277046, 26017485). ClinVar contains an entry for this variant (Variation ID: 36115). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at